ArticleJOR spine2024

Pharmacokinetics of PP353, a formulation of linezolid for intervertebral disc administration, in patients with chronic low back pain and Modic change Type 1: A first-in-human, Phase 1b, open-label, single-dose study.

Shiva S Tripathi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.